基因编辑技术及其在中国的研究发展

doi:10.16288/j.yczz.18-195

遗传 ›› 2018, Vol. 40 ›› Issue (10): 900-915.doi: 10.16288/j.yczz.18-195

基因编辑技术及其在中国的研究发展

陈一欧^1,^4,⁵(),宝颖¹,马华峥¹,伊宗裔^1,^4,⁵,周卓^1,^2,^3,⁶,魏文胜^1,^2,^3,^4,⁶()

^1. 北京大学生命科学学院,北京 100871
^2. 北京大学生物医学前沿创新中心,北京 100871
^3. 北京未来基因诊断高精尖创新中心,北京 100871
^4. 北大-清华生命科学联合中心,北京 100871
^5. 北京大学前沿交叉学科研究院,北京 100871
^6. 北京大学基因组编辑研究中心,北京 100871

收稿日期:2018-07-10 修回日期:2018-09-07 出版日期:2018-10-20 发布日期:2018-09-11
作者简介:陈一欧,博士研究生,专业方向：生物化学与分子生物学。E-mail: cyo1992@hotmail.com
基金资助:
国家自然科学基金项目(31430025)

Gene editing technology and its research progress in China

Yiou Chen^1,^4,⁵(), Ying Bao¹, Huazheng Ma¹, Zongyi Yi^1,^4,⁵, Zhuo Zhou^1,^2,^3,⁶, Wensheng Wei^1,^2,^3,^4,⁶()

^1. School of Life Science, Peking University, Beijing 100871, China
^2. Biomedical Pioneering Innovation Center, Peking University, Beijing 100871, China
^3. Beijing Advanced Innovation Center of Genomics, Beijing 100871, China
^4. PKU-Tsinghua Center for Life Sciences, Beijing 100871, China
^5. Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, China
^6. Peking University Genome Editing Research Center, Beijing 100871, China

Received:2018-07-10 Revised:2018-09-07 Online:2018-10-20 Published:2018-09-11
Supported by:
the National Natural Science Foundation of China(31430025)

摘要/Abstract

摘要：

基因编辑技术是一种能够对生物体的基因组及其转录产物进行定点修饰或者修改的技术,早期基因编辑技术包括归巢内切酶、锌指核酸内切酶和类转录激活因子效应物。近年来,以CRISPR/Cas9系统为代表的新型技术使基因编辑的研究和应用领域得以迅速拓展。本文对基因编辑技术的原理、技术发展及其应用进行了阐述,对我国在基因编辑机制研究及技术发展、基因编辑动植物模型构建、基因治疗等领域的研究进展进行了回顾,并对基因技术的发展前景及趋势进行了展望。

关键词: 基因编辑, 遗传工程, CRISPR, 基因功能, 疾病模型, 基因治疗

Abstract:

Gene editing is a technology for precision modification of genome sequences or expressing transcripts. Early versions of such techniques include homing endonuclease, zinc finger endonuclease and transcription-like activator effectors. The CRISPR/Cas9 system has recently emerged as a powerful and versatile gene editing tool for a broad spectrum of applications. In this review, we discuss the recent development and applications of gene editing technology, and particularly focus on the progress in China, with the emphasis on mechanistic studies, development of new and extended technologies, the applications in animals, plants and the therapeutics.

Key words: gene editing, genetic engineering, CRISPR, gene function, disease model, gene therapy

陈一欧, 宝颖, 马华峥, 伊宗裔, 周卓, 魏文胜. 基因编辑技术及其在中国的研究发展[J]. 遗传, 2018, 40(10): 900-915.

Yiou Chen, Ying Bao, Huazheng Ma, Zongyi Yi, Zhuo Zhou, Wensheng Wei. Gene editing technology and its research progress in China[J]. Hereditas(Beijing), 2018, 40(10): 900-915.

参考文献

[1]	Rudin N, Haber JE . Efficient repair of HO-induced chromosomal breaks in Saccharomyces cerevisiae by recombination between flanking homologous sequences. Mol Cell Biol, 1988,8(9):3918-3928.
[2]	Capecchi MR . Altering the genome by homologous recombination. Science, 1989,244(4910):1288-1292.
[3]	Lin FL, Sperle K, Sternberg N . Recombination in mouse L-cells between DNA introduced into cells and homologous chromosomal sequences. Proc Natl Acad Sci USA, 1985,82(5):1391-1395.
[4]	Jasin M . Genetic manipulation of genomes with rare- cutting endonucleases. Trends Genet, 1996,12(6):224-228.
[5]	Belfort M, Roberts RJ . Homing endonucleases: keeping the house in order. Nucleic Acids Res, 1997,25(17):3379-3388.
[6]	Jeggo PA . DNA breakage and repair. Adv Genet, 1998,38:185-218.
[7]	Smith J, Grizot S, Arnould S, Duclert A, Epinat JC, Chames P, Prieto J, Redondo P, Blanco FJ, Bravo J, Montoya G, Paques F, Duchateau P . A combinatorial approach to create artificial homing endonucleases cleaving chosen sequences. Nucleic Acids Research, 2006,34(22):e149.
[8]	Urnov FD, Miller JC, Lee YL, Beausejour CM, Rock JM, Augustus S, Jamieson AC, Porteus MH, Gregory PD, Holmes MC . Highly efficient endogenous human gene correction using designed zinc-finger nucleases. Nature, 2005,435(7042):646-651.
[9]	Kim YG, Cha J, Chandrasegaran S . Hybrid restriction enzymes: zinc finger fusions to FokⅠ cleavage domain. Proc Natl Acad Sci U S A, 1996,93(3):1156-1160.
[10]	Urnov FD, Rebar EJ, Holmes MC, Zhang HS, Gregory PD . Genome editing with engineered zinc finger nucleases. Nat Rev Genet, 2010,11(9):636-646.
[11]	Li T, Huang S, Jiang WZ, Wright D, Spalding MH, Weeks DP, Yang B . TAL nucleases (TALNs): hybrid proteins composed of TAL effectors and FokⅠ DNA- cleavage domain. Nucleic Acids Res, 2011,39(1):359-372.
[12]	Li T, Huang S, Zhao X, Wright DA, Carpenter S, Spalding MH, Weeks DP, Yang B . Modularly assembled designer TAL effector nucleases for targeted gene knockout and gene replacement in eukaryotes. Nucleic Acids Res, 2011,39(14):6315-6325.
[13]	Christian M, Cermak T, Doyle EL, Schmidt C, Zhang F, Hummel A, Bogdanove AJ, Voytas DF . Targeting DNA double-strand breaks with TAL effector nucleases. Genetics, 2010,186(2):757-761.
[14]	Miller JC, Tan S, Qiao G, Barlow KA, Wang J, Xia DF, Meng X, Paschon DE, Leung E, Hinkley SJ, Dulay GP, Hua KL, Ankoudinova I, Cost GJ, Urnov FD, Zhang HS, Holmes MC, Zhang L, Gregory PD, Rebar EJ . A TALE nuclease architecture for efficient genome editing. Nat Biotechnol, 2011,29(2):143-148.
[15]	Wolfe SA, Nekludova L, Pabo CO . DNA recognition by Cys2His2 zinc finger proteins. Annu Rev Biophys Biomol Struct, 2000,29:183-212.
[16]	Reyon D, Tsai SQ, Khayter C, Foden JA, Sander JD, Joung JK . FLASH assembly of TALENs for high- throughput genome editing. Nat Biotechnol, 2012,30(5):460-465.
[17]	Boettcher M, Mcmanus MT . Choosing the right tool for the job: RNAi, TALEN, or CRISPR. Mol Cell, 2015,58(4):575-585.
[18]	Yang J, Zhang Y, Yuan P, Zhou Y, Cai C, Ren Q, Wen D, Chu C, Qi H, Wei W . Complete decoding of TAL effectors for DNA recognition. Cell Res, 2014,24(5):628-631.
[19]	Zhang Y, Liu L, Guo S, Song J, Zhu C, Yue Z, Wei W, Yi C . Deciphering TAL effectors for 5-methylcytosine and 5-hydroxymethylcytosine recognition. Nat Commun, 2017,8(1):901.
[20]	Ishino Y, Shinagawa H, Makino K, Amemura M, Nakata A . Nucleotide sequence of the iap gene, responsible for alkaline phosphatase isozyme conversion in Escherichia coli, and identification of the gene product. J Bacteriol, 1987,169(12):5429-5433.
[21]	Mojica FJ, Diez-Villasenor C, Soria E, Juez G . Biological significance of a family of regularly spaced repeats in the genomes of Archaea, Bacteria and mitochondria. Mol Microbiol, 2000,36(1):244-246.
[22]	Jansen R, Van Embden JDA, Gaastra W, Schouls LM . Identification of genes that are associated with DNA repeats in prokaryotes. Mol Microbiol, 2002,43(6):1565-1575.
[23]	Bolotin A, Ouinquis B, Sorokin A, Ehrlich SD . Clustered regularly interspaced short palindrome repeats (CRISPRs) have spacers of extrachromosomal origin. Microbiology, 2005,151(Pt 8):2551-2561.
[24]	Makarova KS, Grishin NV, Shabalina SA, Wolf YI, Koonin EV . A putative RNA-interference-based immune system in prokaryotes: computational analysis of the predicted enzymatic machinery, functional analogies with eukaryotic RNAi, and hypothetical mechanisms of action. Biol Direct, 2006,1:7.
[25]	Barrangou R, Fremaux C, Deveau H, Richards M, Boyaval P, Moineau S, Romero DA, Horvath P . CRISPR provides acquired resistance against viruses in prokaryotes. Science, 2007,315(5819):1709-1712.
[26]	Makarova KS, Wolf YI, Alkhnbashi OS, Costa F, Shah SA, Saunders SJ, Barrangou R, Brouns SJ, Charpentier E, Haft DH, Horvath P, Moineau S, Mojica FJ, Terns RM, Terns MP, White MF, Yakunin AF, Garrett RA, Van Der Oost J, Backofen R, Koonin EV . An updated evolutionary classification of CRISPR-Cas systems. Nat Rev Microbiol, 2015,13(11):722-736.
[27]	Shmakov S, Abudayyeh OO, Makarova KS, Wolf YI, Gootenberg JS, Semenova E, Minakhin L, Joung J, Konermann S, Severinov K, Zhang F, Koonin EV . Discovery and functional characterization of diverse Class 2 CRISPR-Cas systems. Mol Cell, 2015,60(3):385-397.
[28]	Zetsche B, Gootenberg JS, Abudayyeh OO, Slaymaker IM, Makarova KS, Essletzbichler P, Volz SE, Joung J, Van Der Oost J, Regev A, Koonin EV, Zhang F . Cpf1 is a single rna-guided endonuclease of a Class 2 CRISPR- Cas system. Cell, 2015,163(3):759-771.
[29]	Cox DBT, Gootenberg JS, Abudayyeh OO, Franklin B, Kellner MJ, Joung J, Zhang F . RNA editing with CRISPR-Cas13. Science, 2017,358(6366):1019-1027.
[30]	Wright AV, Liu JJ, Knott GJ, Doxzen KW, Nogales E, Doudna JA . Structures of the CRISPR genome integration complex. Science, 2017,357(6356):1113.
[31]	Kieper SN, Almendros C, Behler J, Mckenzie RE, Nobrega FL, Haagsma AC, Vink JNA, Hess WR, Brouns SJJ . Cas4 Facilitates PAM-Compatible Spacer Selection during CRISPR adaptation. Cell Rep, 2018,22(13):3377-3384.
[32]	Yosef I, Goren MG, Qimron U . Proteins and DNA elements essential for the CRISPR adaptation process in Escherichia coli. Nucleic Acids Res, 2012,40(12):5569-5576.
[33]	Heler R, Samai P, Modell JW, Weiner C, Goldberg GW, Bikard D, Marraffini LA . Cas9 specifies functional viral targets during CRISPR-Cas adaptation. Nature, 2015,519(7542):199-202.
[34]	Deltcheva E, Chylinski K, Sharma CM, Gonzales K, Chao Y, Pirzada ZA, Eckert MR, Vogel J, Charpentier E . CRISPR RNA maturation by trans-encoded small RNA and host factor RNase Ⅲ. Nature, 2011,471(7340):602-607.
[35]	Barrangou R, Marraffini LA . CRISPR-Cas systems: Prokaryotes upgrade to adaptive immunity. Mol Cell, 2014,54(2):234-244.
[36]	Sternberg SH, Redding S, Jinek M, Greene EC, Doudna JA . DNA interrogation by the CRISPR RNA-guided endonuclease Cas9. Nature, 2014,507(7490):62-67.
[37]	Nishimasu H, Ran FA, Hsu PD, Konermann S, Shehata SI, Dohmae N, Ishitani R, Zhang F, Nureki O . Crystal structure of Cas9 in complex with guide RNA and target DNA. Cell, 2014,156(5):935-949.
[38]	Jinek M, Chylinski K, Fonfara I, Hauer M, Doudna JA, Charpentier E . A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity. Science, 2012,337(6096):816-821.
[39]	Cong L, Ran FA, Cox D, Lin SL, Barretto R, Habib N, Hsu PD, Wu XB, Jiang WY, Marraffini LA, Zhang F . Multiplex genome engineering using CRISPR/Cas systems. Science, 2013,339(6121):819-823.
[40]	Mali P, Yang L, Esvelt KM, Aach J, Guell M, Dicarlo JE, Norville JE, Church GM . RNA-guided human genome engineering via Cas9. Science, 2013,339(6121):823-826.
[41]	Gilbert LA, Horlbeck MA, Adamson B, Villalta JE, Chen Y, Whitehead EH, Guimaraes C, Panning B, Ploegh HL, Bassik MC, Qi LS, Kampmann M, Weissman JS . Genome-scale CRISPR-mediated control of gene repression and activation. Cell, 2014,159(3):647-661.
[42]	Wang H, Yang H, Shivalila CS, Dawlaty MM, Cheng AW, Zhang F, Jaenisch R . One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas- mediated genome engineering. Cell, 2013,153(4):910-918.
[43]	Parnas O, Jovanovic M, Eisenhaure TM, Herbst RH, Dixit A, Ye CJ, Przybylski D, Platt RJ, Tirosh I, Sanjana NE, Shalem O, Satija R, Raychowdhury R, Mertins P, Carr SA, Zhang F, Hacohen N, Regev A . A genome- wide CRISPR screen in primary immune cells to dissect regulatory networks. Cell, 2015,162(3):675-686.
[44]	Zhou Y, Zhu S, Cai C, Yuan P, Li C, Huang Y, Wei W . High-throughput screening of a CRISPR/Cas9 library for functional genomics in human cells. Nature, 2014,509(7501):487-491.
[45]	Shalem O, Sanjana NE, Hartenian E, Shi X, Scott DA, Mikkelson T, Heckl D, Ebert BL, Root DE, Doench JG, Zhang F . Genome-scale CRISPR-Cas9 knockout screening in human cells. Science, 2014,343(6166):84-87.
[46]	Koike-Yusa H, Li Y, Tan EP, Velasco-Herrera Mdel C, Yusa K . Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library. Nat Biotechnol, 2014,32(3):267-273.
[47]	Wang T, Wei JJ, Sabatini DM, Lander ES . Genetic screens in human cells using the CRISPR-Cas9 system. Science, 2014,343(6166):80-84.
[48]	Chen JS, Ma E, Harrington LB, Da Costa M, Tian X, Palefsky JM, Doudna JA . CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity. Science, 2018,360(6387):436-439.
[49]	Qi LS, Larson MH, Gilbert LA, Doudna JA, Weissman JS, Arkin AP, Lim WA . Repurposing CRISPR as an RNA-Guided platform for sequence-specific control of gene expression. Cell, 2013,152(5):1173-1183.
[50]	Hu JH, Miller SM, Geurts MH, Tang W, Chen L, Sun N, Zeina CM, Gao X, Rees HA, Lin Z, Liu DR . Evolved Cas9 variants with broad PAM compatibility and high DNA specificity. Nature, 2018,556(7699):57-63.
[51]	Fonfara I, Richter H, Bratovic M, Le Rhun A, Charpentier E . The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA. Nature, 2016,532(7600):517-521.
[52]	Yamano T, Nishimasu H, Zetsche B, Hirano H, Slaymaker IM, Li YQ, Fedorova I, Nakane T, Makarova KS, Koonin EV, Ishitani R, Zhang F, Nureki O . Crystal structure of Cpf1 in complex with guide RNA and target DNA. Cell, 2016,165(4):949-962.
[53]	Chen JS, Ma EB, Harrington LB, Da Costa M, Tian XR, Palefsky JM, Doudna JA . CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity. Science, 2018,360(6387):436-439.
[54]	Li SY, Cheng QX, Liu JK, Nie XQ, Zhao GP, Wang J . CRISPR-Cas12a has both cis- and trans-cleavage activities on single-stranded DNA. Cell Res, 2018,28(4):491-493.
[55]	Zetsche B, Heidenreich M, Mohanraju P, Fedorova I, Kneppers J, Degennaro EM, Winblad N, Choudhury SR, Abudayyeh O, Gootenberg JS, Wu WY, Scott DA, Severinov K, Van Der Oost J, Zhang F . Multiplex gene editing by CRISPR-Cpf1 using a single crRNA array. Nat Biotechnol, 2017,35(1):31-34.
[56]	Wang MG, Mao YF, Lu YM, Tao XP, Zhu JK . Multiplex gene editing in rice using the CRISPR-Cpf1 system. Mol Plant, 2017,10(7):1011-1013.
[57]	Li XS, Wang Y, Liu YJ, Yang B, Wang X, Wei J, Lu ZY, Zhang YX, Wu J, Huang XX, Yang L, Chen J . Base editing with a Cpf1-cytidine deaminase fusion. Nat Biotechnol, 2018,36(4):324-327.
[58]	Tak YE, Kleinstiver BP, Nunez JK, Hsu JY, Horng JE, Gong JY, Weissman JS, Joung JK . Inducible and multiplex gene regulation using CRISPR-Cpf1-based transcription factors. Nat Methods, 2017,14(12):1163-1166.
[59]	Gao LY, Cox DBT, Yan WX, Manteiga JC, Schneider MW, Yamano T, Nishimasu H, Nureki O, Crosetto N, Zhang F . Engineered Cpf1 variants with altered PAM specificities. Nat Biotechnol, 2017,35(8):789-792.
[60]	Li SY, Zhang X, Wang WS, Guo XP, Wu ZC, Du WM, Zhao YD, Xia LQ . Expanding the scope of CRISPR/ Cpf1-mediated genome editing in rice. Mol Plant, 2018,11(7):995-998.
[61]	Dong, Guo M, Wang S, Zhu Y, Wang S, Xiong Z, Yang J, Xu Z, Huang Z . Structural basis of CRISPR-SpyCas9 inhibition by an anti-CRISPR protein. Nature, 2017,546(7658):436-439.
[62]	Dong D, Ren K, Qiu X, Zheng J, Guo M, Guan X, Liu H, Li N, Zhang B, Yang D, Ma C, Wang S, Wu D, Ma Y, Fan S, Wang J, Gao N, Huang Z . The crystal structure of Cpf1 in complex with CRISPR RNA. Nature, 2016,532(7600):522-526.
[63]	Liu L, Li X, Ma J, Li Z, You L, Wang J, Wang M, Zhang X, Wang Y . The molecular architecture for RNA-guided RNA cleavage by Cas13a. Cell, 2017, 170(4): 714-726.e710.
[64]	Liu L, Li X, Wang J, Wang M, Chen P, Yin M, Li J, Sheng G, Wang Y . Two distant catalytic sites are responsible for C2c2 RNase activities. Cell, 2017, 168(1-2): 121-134.e112.
[65]	Wang J, Li J, Zhao H, Sheng G, Wang M, Yin M, Wang Y . Structural and mechanistic basis of PAM-dependent spacer acquisition in CRISPR-Cas systems. Cell, 2015,163(4):840-853.
[66]	Ma Y, Zhang J, Yin W, Zhang Z, Song Y, Chang X . Targeted AID-mediated mutagenesis (TAM) enables efficient genomic diversification in mammalian cells. Nat Methods, 2016,13(12):1029-1035.
[67]	Li X, Wang Y, Liu Y, Yang B, Wang X, Wei J, Lu Z, Zhang Y, Wu J, Huang X, Yang L, Chen J . Base editing with a Cpf1-cytidine deaminase fusion. Nat Biotechnol, 2018,36(4):324-327.
[68]	Zhu S, Li W, Liu J, Chen CH, Liao Q, Xu P, Xu H, Xiao T, Cao Z, Peng J, Yuan P, Brown M, Liu XS, Wei W . Genome-scale deletion screening of human long non- coding RNAs using a paired-guide RNA CRISPR-Cas9 library. Nat Biotechnol, 2016,34(12):1279-1286.
[69]	Li W, Teng F, Li T, Zhou Q . Simultaneous generation and germline transmission of multiple gene mutations in rat using CRISPR-Cas systems. Nat Biotechnol, 2013,31(8):684-686.
[70]	Yan S, Tu Z, Liu Z, Fan N, Yang H, Yang S, Yang W, Zhao Y, Ouyang Z, Lai C, Yang H, Li L, Liu Q, Shi H, Xu G, Zhao H, Wei H, Pei Z, Li S, Lai L, Li XJ . A huntingtin knockin pig model recapitulates features of selective neurodegeneration in Huntington's disease. Cell, 2018, 173(4): 989- 1002.e1013.
[71]	Ke Q, Li W, Lai X, Chen H, Huang L, Kang Z, Li K, Ren J, Lin X, Zheng H, Huang W, Ma Y, Xu D, Chen Z, Song X, Lin X, Zhuang M, Wang T, Zhuang F, Xi J, Mao FF, Xia H, Lahn BT, Zhou Q, Yang S, Xiang AP . TALEN-based generation of a cynomolgus monkey disease model for human microcephaly. Cell Res, 2016,26(9):1048-1061.
[72]	Chen Y, Yu J, Niu Y, Qin D, Liu H, Li G, Hu Y, Wang J, Lu Y, Kang Y, Jiang Y, Wu K, Li S, Wei J, He J, Wang J, Liu X, Luo Y, Si C, Bai R, Zhang K, Liu J, Huang S, Chen Z, Wang S, Chen X, Bao X, Zhang Q, Li F, Geng R, Liang A, Shen D, Jiang T, Hu X, Ma Y, Ji W, Sun YE . Modeling Rett syndrome using TALEN-edited MECP2 mutant cynomolgus monkeys. Cell, 2017, 169(5): 945-955.e910.
[73]	Yao X, Liu Z, Wang X, Wang Y, Nie YH, Lai L, Sun R, Shi L, Sun Q, Yang H . Generation of knock-in cynomolgus monkey via CRISPR/Cas9 editing. Cell Res, 2018,28(3):379-382.
[74]	Cui Y, Niu Y, Zhou J, Chen Y, Cheng Y, Li S, Ai Z, Chu C, Wang H, Zheng B, Chen X, Sha J, Guo X, Huang X, Ji W . Generation of a precise Oct4-hrGFP knockin cynomolgus monkey model via CRISPR/Cas9-assisted homologous recombination. Cell Res, 2018,28(3):383-386.
[75]	Feng Z, Zhang B, Ding W, Liu X, Yang DL, Wei P, Cao F, Zhu S, Zhang F, Mao Y, Zhu JK . Efficient genome editing in plants using a CRISPR/Cas system. Cell Res, 2013,23(10):1229-1232.
[76]	Zong Y, Wang Y, Li C, Zhang R, Chen K, Ran Y, Qiu JL, Wang D, Gao C . Precise base editing in rice, wheat and maize with a Cas9-cytidine deaminase fusion. Nat Biotechnol, 2017,35(5):438-440.
[77]	Wang Y, Cheng X, Shan Q, Zhang Y, Liu J, Gao C, Qiu JL . Simultaneous editing of three homoeoalleles in hexaploid bread wheat confers heritable resistance to powdery mildew. Nat Biotechnol, 2014,32(9):947-951.
[78]	Shan Q, Wang Y, Li J, Zhang Y, Chen K, Liang Z, Zhang K, Liu J, Xi JJ, Qiu JL, Gao C . Targeted genome modification of crop plants using a CRISPR-Cas system. Nat Biotechnol, 2013,31(8):686-688.
[79]	Ma X, Zhang Q, Zhu Q, Liu W, Chen Y, Qiu R, Wang B, Yang Z, Li H, Lin Y, Xie Y, Shen R, Chen S, Wang Z, Chen Y, Guo J, Chen L, Zhao X, Dong Z, Liu YG . A robust CRISPR/Cas9 system for convenient, high- efficiency multiplex genome editing in monocot and dicot plants. Mol Plant, 2015,8(8):1274-1284.
[80]	Cyranoski D . Chinese scientists to pioneer first human CRISPR trial. Nature, 2016,535(7613):476-477.
[81]	Kim E, Koo T, Park SW, Kim D, Kim K, Cho HY, Song DW, Lee KJ, Jung MH, Kim S, Kim JH, Kim JH, Kim JS . In vivo genome editing with a small Cas9 orthologue derived from Campylobacter jejuni. Nat Commun, 2017,8:14500.
[82]	Tsai SQ, Zheng Z, Nguyen NT, Liebers M, Topkar VV, Thapar V, Wyvekens N, Khayter C, Iafrate AJ, Le LP, Aryee MJ, Joung JK . GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases. Nat Biotechnol, 2015,33(2):187-197.
[83]	Kim D, Bae S, Park J, Kim E, Kim S, Yu HR, Hwang J, Kim JI, Kim JS . Digenome-seq: genome-wide profiling of CRISPR-Cas9 off-target effects in human cells. Nat Methods, 2015,12(3):237-243, 231.
[84]	Slaymaker IM, Gao L, Zetsche B, Scott DA, Yan WX, Zhang F . Rationally engineered Cas9 nucleases with improved specificity. Science, 2016,351(6268):84-88.
[85]	Kleinstiver BP, Pattanayak V, Prew MS, Tsai SQ, Nguyen NT, Zheng Z, Joung JK . High-fidelity CRISPR- Cas9 nucleases with no detectable genome-wide off- target effects. Nature, 2016,529(7587):490-495.
[86]	Chen JS, Dagdas YS, Kleinstiver BP, Welch MM, Sousa AA, Harrington LB, Sternberg SH, Joung JK, Yildiz A, Doudna JA . Enhanced proofreading governs CRISPR- Cas9 targeting accuracy. Nature, 2017,550(7676):407-410.
[87]	Lin S, Staahl BT, Alla RK, Doudna JA . Enhanced homology-directed human genome engineering by controlled timing of CRISPR/Cas9 delivery. eLife, 2014,3:e04766.
[88]	Kim S, Kim D, Cho SW, Kim J, Kim JS . Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins. Genome Res, 2014,24(6):1012-1019.
[89]	Kleinstiver BP, Prew MS, Tsai SQ, Topkar VV, Nguyen NT, Zheng Z, Gonzales AP, Li Z, Peterson RT, Yeh JR, Aryee MJ, Joung JK . Engineered CRISPR-Cas9 nucleases with altered PAM specificities. Nature, 2015,523(7561):481-485.
[90]	Kleinstiver BP, Prew MS, Tsai SQ, Nguyen NT, Topkar VV, Zheng Z, Joung JK . Broadening the targeting range of Staphylococcus aureus CRISPR-Cas9 by modifying PAM recognition. Nat Biotechnol, 2015,33(12):1293-1298.
[91]	Hirano H, Gootenberg JS, Horii T, Abudayyeh OO, Kimura M, Hsu PD, Nakane T, Ishitani R, Hatada I, Zhang F, Nishimasu H, Nureki O . Structure and engineering of Francisella novicida Cas9. Cell, 2016,164(5):950-961.
[92]	Adli M . The CRISPR tool kit for genome editing and beyond. Nat Commun, 2018,9(1):1911.
[93]	Komor AC, Kim YB, Packer MS, Zuris JA, Liu DR . Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage. Nature, 2016,533(7603):420-424.
[94]	Gaudelli NM, Komor AC, Rees HA, Packer MS, Badran AH, Bryson DI, Liu DR . Programmable base editing of AT to GC in genomic DNA without DNA cleavage. Nature, 2017,551(7681):464-471.
[95]	Hess GT, Fresard L, Han K, Lee CH, Li A, Cimprich KA, Montgomery SB, Bassik MC . Directed evolution using dCas9-targeted somatic hypermutation in mammalian cells. Nat Methods, 2016,13(12):1036-1042.
[96]	Kuscu C, Adli M . CRISPR-Cas9-AID base editor is a powerful gain-of-function screening tool. Nat Methods, 2016,13(12):983-984.
[97]	Qi LS, Larson MH, Gilbert LA, Doudna JA, Weissman JS, Arkin AP, Lim WA . Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression. Cell, 2013,152(5):1173-1183.
[98]	Gilbert LA, Larson MH, Morsut L, Liu Z, Brar GA, Torres SE, Stern-Ginossar N, Brandman O, Whitehead EH, Doudna JA, Lim WA, Weissman JS, Qi LS . CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes. Cell, 2013,154(2):442-451.
[99]	Cheng AW, Wang H, Yang H, Shi L, Katz Y, Theunissen TW, Rangarajan S, Shivalila CS, Dadon DB, Jaenisch R . Multiplexed activation of endogenous genes by CRISPR-on, an RNA-guided transcriptional activator system. Cell Res, 2013,23(10):1163-1171.
[100]	Abudayyeh OO, Gootenberg JS, Konermann S, Joung J, Slaymaker IM, Cox DB, Shmakov S, Makarova KS, Semenova E, Minakhin L, Severinov K, Regev A, Lander ES, Koonin EV, Zhang F . C2c2 is a single- component programmable RNA-guided RNA-targeting CRISPR effector. Science, 2016, 353(6299): aaf5573.
[101]	Smargon AA, Cox DBT, Pyzocha NK, Zheng K, Slaymaker IM, Gootenberg JS, Abudayyeh OA, Essletzbichler P, Shmakov S, Makarova KS, Koonin EV, Zhang F . Cas13b is a type VI-B CRISPR-associated RNA-Guided RNase differentially regulated by accessory oroteins Csx27 and Csx28. MolCell, 2017, 65(4): 618-630.e617.
[102]	Shmakov S, Smargon A, Scott D, Cox D, Pyzocha N, Yan W, Abudayyeh OO, Gootenberg JS, Makarova KS, Wolf YI, Severinov K, Zhang F, Koonin EV . Diversity and evolution of class 2 CRISPR-Cas systems. Nat Rev Microbiol, 2017,15(3):169-182.
[103]	Yan WX, Chong S, Zhang H, Makarova KS, Koonin EV, Cheng DR, Scott DA . Cas13d is a compact RNA- targeting type VI CRISPR effector positively modulated by a WYL-domain-containing accessory protein. Mol Cell, 2018, 70(2): 327-339.e325.
[104]	Gootenberg JS, Abudayyeh OO, Kellner MJ, Joung J, Collins JJ, Zhang F . Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6. Science, 2018,360(6387):439-444.
[105]	Shalem O, Sanjana NE, Zhang F . High-throughput functional genomics using CRISPR-Cas9. Nat Rev Genet, 2015,16(5):299-311.
[106]	Liu SJ, Horlbeck MA, Cho SW, Birk HS, Malatesta M, He D, Attenello FJ, Villalta JE, Cho MY, Chen Y, Mandegar MA, Olvera MP, Gilbert LA, Conklin BR, Chang HY, Weissman JS, Lim DA . CRISPRi-based genome-scale identification of functional long noncoding RNA loci in human cells. Science, 2017,355(6320):355.
[107]	Han K, Jeng EE, Hess GT, Morgens DW, Li A, Bassik MC . Synergistic drug combinations for cancer identified in a CRISPR screen for pairwise genetic interactions. Nat Biotechnol, 2017,35(5):463-474.
[108]	Najm FJ, Strand C, Donovan KF, Hegde M, Sanson KR, Vaimberg EW, Sullender ME, Hartenian E, Kalani Z, Fusi N, Listgarten J, Younger ST, Bernstein BE, Root DE, Doench JG . Orthologous CRISPR-Cas9 enzymes for combinatorial genetic screens. Nat Biotechnol, 2018,36(2):179-189.
[109]	Joung J, Engreitz JM, Konermann S, Abudayyeh OO, Verdine VK, Aguet F, Gootenberg JS, Sanjana NE, Wright JB, Fulco CP, Tseng YY, Yoon CH, Boehm JS, Lander ES, Zhang F . Genome-scale activation screen identifies a lncRNA locus regulating a gene neighbourhood. Nature, 2017,548(7667):343-346.
[110]	Sanjana NE, Shalem O, Zhang F . Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods, 2014,11(8):783-784.
[111]	Xue W, Chen S, Yin H, Tammela T, Papagiannakopoulos T, Joshi NS, Cai W, Yang G, Bronson R, Crowley DG, Zhang F, Anderson DG, Sharp PA, Jacks T . CRISPR-mediated direct mutation of cancer genes in the mouse liver. Nature, 2014,514(7522):380-384.
[112]	Choi PS, Meyerson M . Targeted genomic rearrangements using CRISPR/Cas technology. Nat Commun, 2014,5:3728.
[113]	Zuckermann M, Hovestadt V, Knobbe-Thomsen CB, Zapatka M, Northcott PA, Schramm K, Belic J, Jones DT, Tschida B, Moriarity B, Largaespada D, Roussel MF, Korshunov A, Reifenberger G, Pfister SM, Lichter P, Kawauchi D, Gronych J . Somatic CRISPR/Cas9- mediated tumour suppressor disruption enables versatile brain tumour modelling. Nat Commun, 2015,6:7391.
[114]	Carroll KJ, Makarewich CA, Mcanally J, Anderson DM, Zentilin L, Liu N, Giacca M, Bassel-Duby R, Olson EN . A mouse model for adult cardiac-specific gene deletion with CRISPR/Cas9. Proc Natl Acad Sci USA, 2016,113(2):338-343.
[115]	Paquet D, Kwart D, Chen A, Sproul A, Jacob S, Teo S, Olsen KM, Gregg A, Noggle S, Tessier-Lavigne M . Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9. Nature, 2016,533(7601):125-129.
[116]	Gootenberg JS, Abudayyeh OO, Lee JW, Essletzbichler P, Dy AJ, Joung J, Verdine V, Donghia N, Daringer NM, Freije CA, Myhrvold C, Bhattacharyya RP, Livny J, Regev A, Koonin EV, Hung DT, Sabeti PC, Collins JJ, Zhang F . Nucleic acid detection with CRISPR-Cas13a/ C2c2. Science, 2017,356(6336):438-442.
[117]	Wang HX, Li M, Lee CM, Chakraborty S, Kim HW, Bao G, Leong KW . CRISPR/Cas9-based genome editing for disease modeling and therapy: Challenges and opportunities for nonviral delivery. Chem Rev, 2017,117(15):9874-9906.
[118]	Dunbar CE, High KA, Joung JK, Kohn DB, Ozawa K , Sadelain M. Gene therapy comes of age. Science, 2018, 359(6372): pii: eaan4672.
[119]	Boulad F, Mansilla-Soto J, Cabriolu A, Riviere I, Sadelain M . Gene Therapy and genome editing. Hematol Oncol Clin North Am, 2018,32(2):329-342.
[120]	Mansilla-Soto J, Riviere I, Boulad F, Sadelain M . Cell and Gene Therapy for the beta-thalassemias: advances and prospects. Hum Gene Ther, 2016,27(4):295-304.
[121]	Yin H, Xue W, Chen S, Bogorad RL, Benedetti E, Grompe M, Koteliansky V, Sharp PA, Jacks T, Anderson DG . Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype. Nat Biotechnol, 2014,32(6):551-553.
[122]	Dever DP, Bak RO, Reinisch A, Camarena J, Washington G, Nicolas CE, Pavel-Dinu M, Saxena N, Wilkens AB, Mantri S, Uchida N, Hendel A, Narla A, Majeti R, Weinberg KI, Porteus MH . CRISPR/Cas9 beta-globin gene targeting in human haematopoietic stem cells. Nature, 2016,539(7629):384-389.
[123]	Tabebordbar M, Zhu K, Cheng JKW, Chew WL, Widrick JJ, Yan WX, Maesner C, Wu EY, Xiao R, Ran FA, Cong L, Zhang F, Vandenberghe LH, Church GM, Wagers AJ . In vivo gene editing in dystrophic mouse muscle and muscle stem cells. Science, 2016,351(6271):407-411.
[124]	Nelson CE, Hakim CH, Ousterout DG, Thakore PI, Moreb EA, Castellanos Rivera RM, Madhavan S, Pan X, Ran FA, Yan WX, Asokan A, Zhang F, Duan D, Gersbach CA . In vivo genome editing improves muscle function in a mouse model of Duchenne muscular dystrophy. Science, 2016,351(6271):403-407.
[125]	Long C, Amoasii L, Mireault AA, Mcanally JR, Li H, Sanchez-Ortiz E, Bhattacharyya S, Shelton JM, Bassel-Duby R, Olson EN . Postnatal genome editing partially restores dystrophin expression in a mouse model of muscular dystrophy. Science, 2016,351(6271):400-403.
[126]	Gao X, Tao Y, Lamas V, Huang M, Yeh WH, Pan B, Hu YJ, Hu JH, Thompson DB, Shu Y, Li Y, Wang H, Yang S, Xu Q, Polley DB, Liberman MC, Kong WJ, Holt JR, Chen ZY, Liu DR . Treatment of autosomal dominant hearing loss by in vivo delivery of genome editing agents. Nature, 2018,553(7687):217-221.
[127]	Hawksworth J, Satchwell TJ, Meinders M, Daniels DE, Regan F, Thornton NM, Wilson MC, Dobbe JG, Streekstra GJ, Trakarnsanga K, Heesom KJ, Anstee DJ, Frayne J, Toye AM . Enhancement of red blood cell transfusion compatibility using CRISPR-mediated erythroblast gene editing. EMBO Mol Med, 2018,10:e8454.
[128]	Huang YQ, Li GL, Yang HQ, Wu ZF . Progress and application of genome-edited pigs in biomedical research. Hereditas (Beijing), 2018,40(8):632-646.
[128]	黄耀强, 李国玲, 杨化强, 吴珍芳 . 基因编辑猪在生物医学研究中的应用. 遗传, 2018,40(8):632-646.
[129]	Zhang DW, Zhang CF, Dong F, Huang YL, Zhang Y, Zhou H . Application of CRISPR/Cas9 system in breeding of new antiviral plant germplasm. Heredita (Beijing), 2016,38(9):811-820.
[129]	张道微, 张超凡, 董芳, 黄艳岚, 张亚, 周虹 . CRISPR/ Cas9系统在培育抗病毒植物新种质中的应用. 遗传, 2016,38(9):811-820.
[130]	Li J, Meng X, Zong Y, Chen K, Zhang H, Liu J, Li J, Gao C . Gene replacements and insertions in rice by intron targeting using CRISPR-Cas9. Nat Plants, 2016,2:16139.
[131]	Shi J, Gao H, Wang H, Lafitte HR, Archibald RL, Yang M, Hakimi SM, Mo H, Habben JE . ARGOS8 variants generated by CRISPR-Cas9 improve maize grain yield under field drought stress conditions. Plant Biotechnol J, 2017,15(2):207-216.
[132]	Zhou H, He M, Li J, Chen L, Huang Z, Zheng S, Zhu L, Ni E, Jiang D, Zhao B, Zhuang C . Development of commercial thermo-sensitive genic male sterile rice accelerates hybrid rice breeding using the CRISPR/ Cas9-mediated TMS5 editing system. Sci Rep, 2016,6:37395.
[133]	Sun Y, Zhang X, Wu C, He Y, Ma Y, Hou H, Guo X, Du W, Zhao Y, Xia L . Engineering herbicide-resistant rice plants through CRISPR/Cas9-mediated homologous recombination of acetolactate synthase. Mol Plant, 2016,9(4):628-631.
[134]	Wang M, Lu Y, Botella JR, Mao Y, Hua K, Zhu JK . Gene Targeting by homology-directed repair in rice using a geminivirus-based CRISPR/Cas9 system. Mol Plant, 2017,10(7):1007-1010.
[135]	Hai T, Teng F, Guo R, Li W, Zhou Q . One-step generation of knockout pigs by zygote injection of CRISPR/Cas system. Cell Res, 2014,24(3):372-375.
[136]	Liu X, Wang Y, Tian Y, Yu Y, Gao M, Hu G, Su F, Pan S, Luo Y, Guo Z, Quan F, Zhang Y . Generation of mastitis resistance in cows by targeting human lysozyme gene to beta-casein locus using zinc-finger nucleases. Proc Biol Sci, 2014,281(1780):20133368.
[137]	Luo J, Song Z, Yu S, Cui D, Wang B, Ding F, Li S, Dai Y, Li N . Efficient generation of myostatin (MSTN) biallelic mutations in cattle using zinc finger nucleases. PloS One, 2014,9(4):e95225.
[138]	Ni W, Qiao J, Hu S, Zhao X, Regouski M, Yang M, Polejaeva IA, Chen C . Efficient gene knockout in goats using CRISPR/Cas9 system. PloS One, 2014,9(9):e106718.
[139]	Cui C, Song Y, Liu J, Ge H, Li Q, Huang H, Hu L, Zhu H, Jin Y, Zhang Y . Gene targeting by TALEN-induced homologous recombination in goats directs production of beta-lactoglobulin-free, high-human lactoferrin milk. Sci Rep, 2015,5:10482.
[140]	Qian L, Tang M, Yang J, Wang Q, Cai C, Jiang S, Li H, Jiang K, Gao P, Ma D, Chen Y, An X, Li K, Cui W . Targeted mutations in myostatin by zinc-finger nucleases result in double-muscled phenotype in Meishan pigs. Sci Rep, 2015,5:14435.
[141]	Wang K, Ouyang H, Xie Z, Yao C, Guo N, Li M, Jiao H, Pang D . Efficient generation of myostatin mutations in pigs using the CRISPR/Cas9 system. Sci Rep, 2015,5:16623.
[142]	Whitworth KM, Rowland RR, Ewen CL, Trible BR, Kerrigan MA, Cino-Ozuna AG, Samuel MS, Lightner JE, Mclaren DG, Mileham AJ, Wells KD, Prather RS . Gene-edited pigs are protected from porcine reproductive and respiratory syndrome virus. Nat Biotechnol, 2016,34(1):20-22.

编辑推荐

Metrics

www.chinagene.cn
备案号：京ICP备09063187号-4
总访问:,今日访问:,当前在线:

基因编辑技术及其在中国的研究发展

Gene editing technology and its research progress in China

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

[1]	宗媛,高彩霞. 碱基编辑系统研究进展[J]. 遗传, 2019, 41(9): 777-800.
[2]	杨新萍,于媛,许操. 重新设计与快速驯化创造新型作物[J]. 遗传, 2019, 41(9): 827-835.
[3]	张倩倩,商璇,林宛颖,徐湘民. 影响β-地中海贫血表型的遗传修饰作用[J]. 遗传, 2019, 41(8): 669-676.
[4]	牛煦然,尹树明,陈曦,邵婷婷,李大力. 基因编辑技术及其在疾病治疗中的研究进展[J]. 遗传, 2019, 41(7): 582-598.
[5]	郑晓飞,黄海燕,吴强. 染色质架构蛋白CTCF调控UGT1基因簇的表达[J]. 遗传, 2019, 41(6): 509-523.
[6]	王珏, 黄娟, 许蕊. 利用CRISPR/Cas9和piggyBac实现果蝇基因组无缝编辑[J]. 遗传, 2019, 41(5): 422-429.
[7]	欧浩,李国玲,王豪强,黄广燕,蔡更元,李紫聪,吴珍芳,张献伟. MEK抑制剂PD0325901显著提高猪胎儿成纤维细胞ssODN介导的HDR效率[J]. 遗传, 2019, 41(4): 327-336.
[8]	张楷, 刘蔚, 刘小凤, 陈瑶生, 刘小红, 何祖勇. 利用CRISPR/Cas9系统构建人HPRT1基因定点突变细胞株[J]. 遗传, 2019, 41(10): 939-949.
[9]	刘恒, 李东明, 朱兰玉, 赖乐锦, 闫婉云, 陆玉双, 韦伊, 黄月琪, 方媚, 苏元港, 杨芳, 舒伟. 利用CRISPR/Cas9敲除人源细胞系中LMNA基因的研究[J]. 遗传, 2019, 41(1): 66-75.
[10]	任云晓, 肖茹丹, 娄晓敏, 方向东. 基因编辑技术及其在基因治疗中的应用[J]. 遗传, 2019, 41(1): 18-27.
[11]	张桂珊, 杨勇, 张灵敏, 戴宪华. 机器学习方法在CRISPR/Cas9系统中的应用[J]. 遗传, 2018, 40(9): 704-723.
[12]	黄耀强,李国玲,杨化强,吴珍芳. 基因编辑猪在生物医学研究中的应用[J]. 遗传, 2018, 40(8): 632-646.
[13]	刘海龙, 谌阳, 高杨, 周玲, 韩晓松, 赵长志, 杨高娟, 陈毅龙, 杨慧, 谢胜松. 靶向miRNA前体不同类型sgRNA的丰度及特异性评估[J]. 遗传, 2018, 40(7): 561-571.
[14]	唐浚博, 曹浩伟, 许蕊, 张丹丹, 黄娟. 果蝇睾丸基因敲除突变体的构建及表型分析[J]. 遗传, 2018, 40(6): 478-487.
[15]	李慧卿, 陈超, 陈冉冉, 宋雪薇, 李佶娜, 朱延明, 丁晓东. 利用CRISPR/Cas9双基因敲除系统初步解析大豆GmSnRK1.1和GmSnRK1.2对ABA及碱胁迫的响应[J]. 遗传, 2018, 40(6): 496-507.